Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells

Details for Australian Patent Application No. 2001267780 (hide)

International Classifications

Event Publications

12 June 2003 Amendment Made

The nature of the amendment is: Add the co-applicant/patentee University of Maryland

16 September 2004 Assignment before Grant

University of Maryland; Altarex Corp. The application has been assigned to University of Maryland; AltaRex Medical Corp.

13 July 2006 Application Accepted

Published as AU-B-2001267780

9 November 2006 Standard Patent Sealed

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.